Trial intelligence / Profile preview

Probiotics for Oral Candidosis Prophylaxis in Sjogren's Syndrome

NCT03840538Phase 2Completed

Sponsor
Cairo University
Start
Jan 2018
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in oral candidiasis (2 arms), sponsored by Cairo University. Primary endpoint: Pain assessment at 5 weeks. Started Jan 2018; status: completed.

02

Conditions

oral candidiasis

Beyond the preview

Go deeper on NCT03840538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03840538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call